|
Quotes & Info
|
| AVNR > SEC Filings for AVNR > Form 8-K on 5-Jun-2012 | All Recent SEC Filings |
5-Jun-2012
Creation of a Direct Financial Obligation or an Obligation under an
Pursuant to the Loan and Security Agreement (the "Loan Agreement") Avanir Pharmaceuticals, Inc. (the "Company") entered into on May 7, 2012 with Oxford Finance LLC, as a lender and as collateral agent, and Silicon Valley Bank, as a lender, on June 4, 2012 the Company borrowed $30.0 million. The terms of payment of the $30.0 million, including the material terms under which such obligation may be accelerated or increased, as well as a description of the material terms of the Loan Agreement, are included in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 9, 2012.
* * *
|
|